Roche Distribution Agreement

A complete list of the products contained will be available on the following websites: or Please sign up to receive updated information as it becomes available. In 2014, the Roche Group employed 88,500 people worldwide, invested CHF 8.9 billion in research and development and generated sales of CHF 47.5 billion. Genentech in the United States is a 100% member of the Roche Group. Roche is the majority shareholder of Chugai Pharmaceutical in Japan. For more information, see This agreement includes the exclusive distribution of Roche products for the following product lines in all regions except Brazil: the exclusive global distribution agreement includes rock replacement biochemicals, including proteomics, cell analysis and conventional PCR applications.